Monetization through licensing out intellectual property
First written in FY2016. 1 of 2 entries say "Advanced", first in FY2017. Latest entry: FY2017.
No other company in this theme has enough history to compare yet.
- FY2017AdvancedAnnual report
「Regarding the production and commercialisation of an antibody serving as a depression marker through joint research with the National Institute of Advanced Industrial Science and Technology, the licensee is preparing to begin sales.」
The licensee has reached the preparation stage for launching sales, giving concrete shape to the commercialisation and monetisation of intellectual property through out-licensing. - FY2016First statedAnnual report
「In December last year, we entered into a licensing agreement with a global healthcare company for the exclusive worldwide right to manufacture and sell a diagnostic product using a specific antibody produced by the company with GANP® mouse technology. We will receive consideration from the company, including milestones based on development progress and royalties based on sales.」
The Company entered into an agreement to grant exclusive worldwide manufacturing and sales rights for a diagnostic product using GANP® mouse technology, in return for milestones and sales royalties.